REVIEW
Accepted on 30 Oct 2025
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immuno-metabolic Approaches for the Treatment of Hepatobiliary and Pancreatic Tumors
Immuno-metabolic Approaches for the Treatment of Hepatobiliary and Pancreatic Tumors
4,190
Total downloads
19k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
CASE REPORT
Accepted on 27 Oct 2025
Pembrolizumab combined with surgical treatment for spontaneously ruptured undifferentiated pleomorphic sarcoma of the liver: A case report and literature review
- 161 views
ORIGINAL RESEARCH
Published on 22 Oct 2025
Prognostic analysis of different postoperative adjuvant therapies for patients with hepatocellular carcinoma after radical resection with high-risk recurrence factors: a multicenter real-world retrospective study
doi 10.3389/fimmu.2025.1661923
- 450 views
ORIGINAL RESEARCH
Published on 22 Sep 2025
Development of a nomogram integrating immune checkpoints, fibrosis indicators, and clinicopathological characteristics to predict overall survival in pancreatic cancer: a retrospective analysis
doi 10.3389/fimmu.2025.1688440
- 881 views
ORIGINAL RESEARCH
Published on 12 Sep 2025
Hepatic arterial interventional therapies alone or in combination with molecular targeted therapies and PD-(L)1 inhibitors in locally aggressive, early recurrent hepatocellular carcinoma: a retrospective study
doi 10.3389/fimmu.2025.1643082
- 996 views
REVIEW
Published on 08 Aug 2025
Immunotherapy in biliary tract cancer: reshaping the tumour microenvironment and advancing precision combination strategies
doi 10.3389/fimmu.2025.1651769
- 2,492 views
ORIGINAL RESEARCH
Published on 03 Jul 2025
Serum GDF15 level as predictive biomarker of clinical outcome in patients with unresectable hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy
doi 10.3389/fimmu.2025.1619387
- 1,481 views
- 1 citation
ORIGINAL RESEARCH
Published on 12 Jun 2025
PD-1 inhibitor-augmented HAIC-TKI therapy in hepatocellular carcinoma with portal vein tumor thrombosis: real-world survival benefits, safety, and subgroup-specific efficacy
doi 10.3389/fimmu.2025.1602031
- 2,368 views
- 2 citations
ORIGINAL RESEARCH
Published on 11 Jun 2025
Utilization of artificial circular RNAs as miRNA sponges and anti-PD-1 scFv expression platforms to suppress hepatocellular carcinoma progression
doi 10.3389/fimmu.2025.1609165
- 1,882 views
- 1 citation
ORIGINAL RESEARCH
Published on 14 Apr 2025
Heterogenous cancer-associated fibroblasts related tumor microenvironment marked by CD10/KLF4/TIAM1 were identified in pancreatic adenocarcinoma by integrated transcriptomics
doi 10.3389/fimmu.2025.1557698
- 3,832 views
- 4 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: